Publications by authors named "F ROGERS"

Diabetic retinopathy (DR) is a public health issue affecting millions in the United States and Europe. However, despite strong recommendations for screening at regular intervals by many professional societies, including the American Diabetes Association and the American Academy of Ophthalmology, screening rates remain suboptimal, with only 50-70% of patients with diabetes adhering to recommended annual eye exams. Barriers to screening include lack of awareness, socioeconomic factors, health care system fragmentation, and workforce shortages, among others.

View Article and Find Full Text PDF

Introduction: Damage Control Surgery (DCS) is a surgical technique used to manage critically ill and injured patients. This study examines the most recent 10-y outcomes related to DCS, with the secondary goal of scrutinizing the outcomes after DCS across surgical theaters.

Methods: Studies published between 2012 and 2021 that described adult patients undergoing Abdominal DCS after traumatic injury were included.

View Article and Find Full Text PDF

Increasing trauma center admission volume is said to decrease mortality. Evidence supporting this position is dependent upon patient groups and the time period studied, and gaps remain. We evaluated the effect of annual volume of critically injured patients on hospital mortality, comparing two time periods.

View Article and Find Full Text PDF

This real-world study explored factors affecting persistence with macitentan and selexipag treatment from the perspective of 23 healthcare professionals (HCPs) and 134 patients with pulmonary arterial hypertension between 2019 and 2022. Continuous patient/HCP communication and education were key drivers of persistence, as were early discussion and management of side effects.

View Article and Find Full Text PDF
Article Synopsis
  • Monoclonal antibody therapies for cancer have seen significant success but are primarily focused on specific cell surface antigens, leaving many potential targets inside cells untapped.
  • Recent research has focused on humanizing a lupus-derived autoantibody, 3E10, which can penetrate cells and target tumors effectively.
  • The study found that the efficiency of this cell uptake relies on a specific transporter and that a particular human variant of 3E10 retains the ability to bind to RAD51, potentially enhancing cancer treatment by inhibiting DNA repair mechanisms.
View Article and Find Full Text PDF